Global Innovation Summit 2026

Global Innovation Summit 2026

Welcome to the Global Innovation Summit!

The Global Innovation Summit 2026 is your opportunity to kick off your innovation project with international partners, strengthen your business and explore suitable funding opportunities in over 40 countries.

The one-day event will take place on Wednesday, 6 May 2026 at Messe Basel, Switzerland.

Why attend the Global Innovation Summit 2026?

The Global Innovation Summit is a recurring gathering organised in the framework of Eureka the world’s largest network for supporting collaborative innovation.

The 2026 edition is organised by the Swiss Eureka Chair represented by Innosuisse and focuses on innovation in the biotech industry combined with enabling technologies and services like digitalisation, translational research and development, chemistry, manufacturing, control and quality control processes, etc.

It will feature an international public, inspiring keynotes and a strong focus on matchmaking for international projects. With a thousand participants expected, the Summit offers a unique chance to turn your ideas into action on a global scale.

The Global Innovation Summit runs back-to-back with the annual Swiss Biotech Day and aims at linking the Swiss biotech ecosystem with global businesses and science to strengthen international cooperation.

  • 🌍 Explore international collaboration.
  • 🤝 Make meaningful connections for project funding.
  • 🎤 Learn from industry leaders.
  • 💡 Get inspired.
  • 🚀 Stay ahead of the curve.
  • 🎉 Enjoy the experience.
  • ✨ Attend free of charge.

Take the opportunity to connect, exchange ideas and collaborate. Register now!

register now

Our latest News

discover more
How is TR-FRET Used in Drug Discovery?

How is TR-FRET Used in Drug Discovery?

This post is Part 2 of a two-part blog series. Read part 1: What is a TR‑FRET assay and how is it used in drug discovery? In a previous blog post, we covered the fundamental principles of Time-Resolved Fluorescence (TR) Förster Resonance Energy Transfer (TR-FRET), including how long-lived lanthanide donors like europium enable high-sensitivity, “mix-and-read” assays. Because TR-FRET provides a ratiometric, proximity-based […]

Triple ERC Success at the German Cancer Research Center

Triple ERC Success at the German Cancer Research Center

Three researchers at the German Cancer Research Center (DKFZ) have each been awarded a Starting Grant from the European Research Council (ERC) this year. Daniel Kirschenbaum, Lena Kutscher, and Michael Scherer impressed the ERC with their innovative research approaches to fundamental questions in cancer medicine. With the funding, they plan to investigate why certain brain […]

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich (TUM) have identified a previously unknown mechanism that can drive cancer cachexia – a wasting process in the body that primarily affects muscle and fat tissue. A central role is […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp